知镜 Cognispect · 医学文献与研究工作台

Microvascular damage in diabetic nephropathy and the subsequent risk of Alzheimer's disease: a systematic review.

Mohammed N, Alyazan Khalil Taher Al-Jabali T, Yassien N, Osman Abufatima I, Omer Ibrahim Ahmed F, El Yazal S, Satti W, Alalamat N, Aamer Abkar Ibrahim M, Tirelbar B, Paudel L, Abdalla Abdelsadig Mahmoud I, Humdi L, Ali H, Hammad Jaber Amin M, Abdelrahman N.
Annals of medicine and surgery (2012) · 2026-08-21 · PMID 42724815

文献摘要

Introduction Diabetic nephropathy (DN), a major microvascular complication of diabetes, is increasingly implicated in systemic vascular dysfunction and may contribute to the pathogenesis of Alzheimer's disease (AD). Microvascular injury is a recognized mechanism in AD, and DN-related damage may raise the risk of cognitive decline. Methods Following the PRISMA 2020 guidelines, we searched PubMed, Scopus, and the Cochrane Library (2000-2025) for studies on DN-related vascular damage and cognitive outcomes. Quality was assessed using the Newcastle-Ottawa Scale and the AXIS tool. Results Of 275 records, nine studies were included (cross-sectional and longitudinal, with up to 37.5 years of follow-up). DN was measured via eGFR, albuminuria, the fibrinogen-to-albumin ratio, or ICD codes; cognition via assessed using amyloid PET, neurocognitive tests, or registry data. All studies found that impaired kidney function was associated with a greater risk of AD or cognitive decline. Conclusion Available evidence links DN-related microvascular damage to a higher risk of AD, suggesting a kidney-brain axis. However, causality remains uncertain and requires longitudinal and mechanistic studies to clarify these pathways.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。